Scott Dalgleish - 21 Mar 2022 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Reporting relationship: Chief Financial Officer
Issuer ticker: TOI
Reported as of: 21 Mar 2022
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 29 Mar 2022, 20:10:43 UTC
Original report date: 23 Mar 2022
Prior SEC filing: 16 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Scott Dalgleish

Key filing fact

Scott Dalgleish filed Form 4/A - Amendment for Oncology Institute, Inc. (TOI) on 29 Mar 2022.

Key facts

This page summarizes Scott Dalgleish's Form 4/A - Amendment filing for Oncology Institute, Inc. (TOI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Mar 2022, 20:10.

Change

Previous filing in this sequence was filed on 16 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TOI transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +162,891
Change %
Price: $0.000000
Shares after: 162,891
Date: 21 Mar 2022
Ownership: Direct
Underlying class: Common stock
Underlying amount: 162,891
Exercise price: $7.09
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options vest as to 1/3rd of the options granted on the second anniversary of November 12, 2021 (the "Vesting Commencement Date"), with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

SEC remarks

This amendment is filed to correct the number of options granted due to an administrative error in applying the grant amount calculations.